Literature DB >> 10438903

Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells.

J Gerwien1, M Nielsen, T Labuda, M H Nissen, A Svejgaard, C Geisler, C Röpke, N Odum.   

Abstract

Recent data show that TCR/CD3 stimulation induces activation of Stat5 in murine T cells. Here, we show that CD3 ligation by mAb and Staphylococcal enterotoxin (SE) induce a rapid, gradually accumulating, long-lasting tyrosine, and serine phosphorylation of Stat3 (but not Stat5) in allogen-specific human CD4+ T cell lines. In contrast, IL-2 induces a rapid and transient tyrosine and serine phosphorylation of Stat3. Compared with IL-2, CD3 ligation induces a delayed Stat3 binding to oligonucleotide probes from the ICAM-1 and IL-2R alpha promoter. CD3-mediated activation of Stat3 is almost completely inhibited by a Src kinase inhibitor (PP1), whereas IL-2-induced Stat3 activation is unaffected. In conclusion, we show that CD3 ligation by mAb and SE triggers a rapid, PP1-sensitive tyrosine and serine phosphorylation of Stat3 in human CD4+ T cells. Moreover, we provide evidence that TCR/CD3 and IL-2 induce Stat3 activation via distinct signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Altered T-cell receptor signaling in the pathogenesis of allergic disease.

Authors:  Shrimati Datta; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

2.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.

Authors:  Lindsay J Edwards; Masayuki Mizui; Vasileios Kyttaris
Journal:  Clin Immunol       Date:  2015-04-11       Impact factor: 3.969

5.  The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.

Authors:  B Rödel; K Tavassoli; H Karsunky; T Schmidt; M Bachmann; F Schaper; P Heinrich; K Shuai; H P Elsässer; T Möröy
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

6.  Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.

Authors:  Wendy A Goodman; Andrew B Young; Thomas S McCormick; Kevin D Cooper; Alan D Levine
Journal:  J Immunol       Date:  2011-02-09       Impact factor: 5.422

7.  Staphylococcal enterotoxin H contrasts closely related enterotoxins in species reactivity.

Authors:  Helen Pettersson; Göran Forsberg
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

8.  Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10.

Authors:  Derek D Sloan; Keith R Jerome
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK.

Authors:  Wei Jin; Xiao-Fei Zhou; Jiayi Yu; Xuhong Cheng; Shao-Cong Sun
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

10.  Integrating signals from the T-cell receptor and the interleukin-2 receptor.

Authors:  Tilo Beyer; Mandy Busse; Kroum Hristov; Slavyana Gurbiel; Michal Smida; Utz-Uwe Haus; Kathrin Ballerstein; Frank Pfeuffer; Robert Weismantel; Burkhart Schraven; Jonathan A Lindquist
Journal:  PLoS Comput Biol       Date:  2011-08-04       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.